Full Press Release Details
Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA.
REGN
Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA
Key Takeaway: Regeneron and Sanofi Announce Sarilumab Biologics License Application Accepted for Review by US FDA